ArticleCyborg and bionic systems (Washington, D.C.)2026
RST2G: Residual-Guided Spatiotemporal Transformer Graph Fusion Enhancement for Breast Cancer Segmentation in DCE-MRI.
Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate segmentation of breast tumors in dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is essential for effective diagnosis, treatment planning, and monitoring of breast cancer. However, the high heterogeneity of tumor appearance and the complex spatiotemporal dynamics of contrast enhancement present critical challenges for existing segmentation methods. In this study, we propose a novel residual-guided spatiotemporal transformer with graph fusion enhancement (RST2G) framework for precise breast tumor segmentation in DCE-MRI. RST2G explicitly leverages pre-contrast MRI, post-contrast MRI, and their residual differences to capture rich inter-temporal kinetic information. Specifically, RST2G employs a weight-sharing hybrid encoder that combines convolutional neural networks and vision transformers to extract local and global features, followed by a residual-guided multi-scale refinement module to enhance feature discriminability. To effectively model spatial and temporal contextual dependencies, we construct modality-specific graphs and apply inter-slice and inter-temporal attention mechanisms for spatiotemporal graph enhancement. Extensive experiments on 2 publicly available breast DCE-MRI datasets demonstrate that RST2G significantly outperforms state-of-the-art 2-dimensional (2D), 3D, and 4D segmentation methods. Given its effectiveness in capturing complex spatiotemporal tumor characteristics for cancer annotation, RST2G has the potential to improve clinical breast cancer treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.